Evidence map›Paper›PMID 39744336›Full record

ArticleCurrent medical mycology2024

Abolfazl Shakeri, Aliakbar Mashhadi Esmaeilabadi, Vahid Soheili, Javad Mottaghipisheh, Seyed Ahmad Emami, Javad Akhtari, Zahra Tayarani-Najaran

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current medical mycology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abolfazl ShakeriDepartment of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Aliakbar Mashhadi EsmaeilabadiDepartment of Pharmacognosy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Vahid SoheiliDepartment of Pharmaceutical Control, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Javad MottaghipishehDepartment of Aquatic Sciences and Assessment, Swedish University of Agricultural Sciences, SE, 75007, Uppsala, Sweden.
Seyed Ahmad EmamiDepartment of Traditional Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Javad AkhtariImmunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Zahra Tayarani-NajaranDepartment of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: Materials and Methods: The methanolic crude extract (MeOH) and its sub-fractions, including petroleum ether (PE), dichloromethane (DCM), ethyl acetate (EtOAc), and n-butanol (n-BuOH) were prepared. Results: Results from the antifungal and antibacterial activities of fractions indicated remarkable antifungal effects against Conclusion: It can be concluded that strong antifungal and antioxidant activities without notable cytotoxicity, suggest the potential safety of the plant to be used as a natural antifungal remedy as well as a preservative in the food industry.

Indexed as

AntimicrobialApiaceaeCandida albicansCytotoxicity

Identifiers

PMID39744336
PMCPMC11686930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.